Covaxin likely to get WHO approval for emergency use

| | New Delhi
  • 6

Covaxin likely to get WHO approval for emergency use

Tuesday, 31 August 2021 | PNS | New Delhi

Hyderabad-based Bharat Biotech is likely to get approval from the World Health Organization in two weeks for the emergency use listing (EUL) of its Covaxin vaccine, according to NK Arora, who is heading the National Technical Advisory Group on Immunisation (NTAGI.

EUL is a WHO procedure through which it assesses the medicines, vaccines and devices used to address an outbreak classified as a ‘public health emergency of international concern’. With the approval for EUL, Bharat Biotech will be able to supply its vaccine to other countries. The Hyderabad-based company had applied to WHO for EUL in the second week of July.

Covaxin, the company’s home-grown Covid-19 vaccine approved for emergency use in India, is one of two shots driving the country’s massive vaccination programme launched on January 16.

On Sunday, the company rolled out the first batch of Covaxin shots from a facility in Ankleshwar in western India that has the capacity to produce more than 1 crore doses per month.

Sunday Edition

Time to awaken Corporate Social Consciousness?

28 November 2021 | Priya Nair Rajeev / Simy Joy | Agenda

Exquisite prose poetry

28 November 2021 | Swati Pal | Agenda

From uncertainty to probabilities

28 November 2021 | Pradeep | Agenda

New arrivals

28 November 2021 | Pioneer | Agenda

Astroturf : Choice sets premise of destiny

28 November 2021 | Bharat Bhushan Padmadeo | Agenda

Talktime : ‘I want to be part of cinema & not just project making'

28 November 2021 | Shalini Saksena | Sunday Pioneer